| Literature DB >> 36109712 |
Kwangwon Seo1,2, Kyung-Hyo Do3, Wan-Kyu Lee4.
Abstract
OBJECTIVES: Colibacillosis is a frequent enteric disease in the pig industry that causes significant economic losses. The objective of this study was to investigate the molecular characteristics of fluoroquinolone (FQ)-resistant E. coli isolates from suckling piglets with colibacillosis.Entities:
Keywords: Antimicrobial resistance; Colibacillosis; Escherichia coli; Fluoroquinolone; Plasmid-mediated quinolone resistance
Mesh:
Substances:
Year: 2022 PMID: 36109712 PMCID: PMC9476276 DOI: 10.1186/s12866-022-02632-9
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 4.465
Distribution of multi-drug resistance patterns among 43 fluoroquinolone-resistance E. coli isolates
| No. of classes | Antimicrobial resistance class pattern | Frequency | Prevalence (%) |
|---|---|---|---|
| 11 | AMGs, BL/BLICs, CEPs, FQs, FPIs, MONs, PCNs, PHs, PPs, Qs, TETs | 1 | 2.3 |
| 10 | AMGs, BL/BLICs, CEPs, FQs, FPIs, MONs, PCNs, PHs, Qs, TETs | 4 | 9.3 |
| AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, PPs, Qs, TETs | 3 | 7.0 | |
| 9 | AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, Qs, TETs | 16 | 37.2 |
| AMGs, BL/BLICs, FQs, FPIs, MONs, PCNs, PHs, Qs, TETs | 1 | 2.3 | |
| 8 | AMGs, BL/BLICs, FQs, FPIs, PCNs, PHs, Qs, TETs | 4 | 9.3 |
| AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, Qs, TETs | 2 | 4.7 | |
| AMGs, CEPs, FQs, PCNs, PHs, PPs, Qs, TETs | 1 | 2.3 | |
| AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, Qs | 1 | 2.3 | |
| 7 | AMGs, CEPs, FQs, MONs, PCNs, Qs, TETs | 1 | 2.3 |
| AMGs, CEPs, FQs, PCNs, PHs, Qs, TETs | 1 | 2.3 | |
| AMGs, FQs, PCNs, PHs, PPs, Qs, TETs | 1 | 2.3 | |
| 6 | AMGs, FQs, PCNs, PHs, Qs, TETs | 6 | 14.0 |
| AMGs, CEPs, FQs, PCNs, Qs, TETs | 1 | 2.3 | |
| Total | 43 | 100.0 |
AMGs Aminoglycosides, BL/BLICs β-lactam/β-lactamase inhibitor combinations, CEPs, Cephems, FQs Fluoroquinolones, FPIs Folate pathway inhibitors, MONs Monobactams, PCNs Penicillins, PHs, Phenicols, PPs Polypeptides, Qs Quionolones, TETs Tetracyclines
Amino acid changes in the QRDRs, MICs and PMQR determinants of 43 fluoroquinolone-resistance E. coli isolates
| O Serogroupa | PMQR genesb | QRDR mutations | MICs (mg/mL) | ||||
|---|---|---|---|---|---|---|---|
| CIP | ENR | NOR | |||||
| O2 | S83L | WT | 4 | 8 | 8 | ||
| O8 | - | S83L/D87E | WT | 8 | 16 | 16 | |
| O8 | - | S83L/D87N | S80I | 16 | 32 | 32 | |
| O9 | - | S83L | S80W | 16 | 64 | 32 | |
| O11 | - | S83L/D87N | S80I/E84A | 64 | 256 | 256 | |
| O11 | - | S83L/D87N | S80I | 16 | 64 | 256 | |
| O14 | S83L | WT | 8 | 16 | 16 | ||
| O27 | - | S83L/D87N | S80I | 16 | 64 | 256 | |
| O27 | S83L | S80N | 16 | 64 | 32 | ||
| O78 | - | S83L, D87N | S80I | 8 | 16 | 32 | |
| O101 | - | S83L, D87N | S80I | 8 | 16 | 16 | |
| O101 | - | S83L, D87N | S80I | 16 | 64 | 128 | |
| O101 | - | S83L, D87N | S80I, E84A | 64 | 128 | 256 | |
| O116 | - | S83L | S80I | 4 | 16 | 8 | |
| O119 | - | S83L | S80I | 8 | 32 | 32 | |
| O127 | - | S83L, D87N | S80I, E84A | 64 | 256 | 256 | |
| O127 | - | S83L, D87N | S80I | 16 | 64 | 32 | |
| O127 | S83L, D87N | S80I | 32 | 128 | 256 | ||
| O147 | - | S83L, D87N | S80K | 16 | 32 | 32 | |
| O149 | S83L | A56C, S57Q, S80R | 32 | 64 | 64 | ||
| O149 | - | S83L, D87G | S80K | 8 | 32 | 16 | |
| O149 | S83L, D87E | WT | 16 | 32 | 32 | ||
| O149 | - | S83L | E84G | 16 | 64 | 128 | |
| O149 | S83L | S80R | 8 | 16 | 32 | ||
| O149 | S83L | S80R | 8 | 32 | 32 | ||
| O149 | - | S83L, D87N | S80I | 16 | 32 | 32 | |
| O149 | - | S83L | S80R | 8 | 32 | 16 | |
| O149 | S83L, D87N | S80I, E84A | 256 | 512 | 512 | ||
| O149 | S83L | S80R | 4 | 16 | 16 | ||
| O149 | - | S83L | S80R | 4 | 16 | 8 | |
| O149 | - | S83L, D87N | S80I | 8 | 16 | 8 | |
| O157 | - | S83L, D87N | S80K | 8 | 16 | 16 | |
| O159 | S83L, D87N | S80I | 16 | 128 | 256 | ||
| O167 | - | S83L, D87N | S80I | 16 | 64 | 16 | |
| O167 | - | S83L | S80I | 4 | 8 | 8 | |
| O182 | - | S83L, D87G | S80R | 8 | 32 | 16 | |
| ONT | - | S83L, D87N | S80I | 16 | 32 | 16 | |
| ONT | - | S83L, D87N | S80I | 16 | 64 | 128 | |
| ONT | S83L, D87N | S80I | 32 | 128 | 256 | ||
| ONT | - | S83L, D87G | S80I | 8 | 16 | 16 | |
| ONT | - | S83L, D87N | S80R | 8 | 8 | 16 | |
| ONT | - | S83L, D87G | S80R | 8 | 16 | 16 | |
| ONT | - | S83L, D87G | S80I, E84A | 64 | 128 | 256 | |
PMQR Plasmid-mediated quinolone resistance, QRDR Quinolone-resistance determining region, WT Wild type, MICs Minimum inhibitory concentrations, CIP Ciprofloxacin, ENR Enrofloxacin, NOR Norfloxacin
aONT, not detected
b-, not detected
Phenotypes and genotypes of 12 PMQR-positive E. coli isolates
| Isolate | PMQR gene | Resistance phenotypes | Resistance genes | Integron and gene cassettes | Plasmid replicon type | Virotype |
|---|---|---|---|---|---|---|
| EAST1 | ||||||
| SSC-23 | AM, AMC, AN, C, CF, CZ, D, GM, K, N, NA, P, S, SXT, TE | I ( | FIB, I1, P | EAST1 | ||
| FIB, | F4:paa:LT:STb:EAST1 | |||||
| F4:F41:STa:STb:EAST1 | ||||||
| FIB, FIC, HI1, N | F4:LT:STb:EAST1 | |||||
| SSC-33 | AM, AMC, C, D, GM, K, N, NA, P, S, SXT, TE | I (-) | FIA, FIB, FIC, HI1, N, Y | F4:paa:AIDA:LT:STb:EAST1 | ||
| SSC-35 | AMC, CF, D, GM, K, N, NA, P, S, TE | I ( | FIB, I1, X | STa | ||
| SSC-37 | AM, AMC, C, D, GM, K, N, NA, P, S, SXT, TE | I (-) | FIB, FIC, HI1, N | F4:paa:AIDA:LT:STa:STb | ||
| SSC-38 | AM, AMC, C, CF, CZ, D, GM, K, N, NA, P, S, SXT, TE | I (-) | FIB, FIC, HI1, N | EAST1 | ||
| LT:STb:EAST1 | ||||||
| FIA, | F4:LT:STb:EAST1 | |||||
| A/C, | F4:F41:STa:STb |
Underline indicate that was found in the transconjugant strains
PMQR Plasmid-mediated quinolone resistance, AM Ampicillin, AMC Amoxicillin-clavulanic acid, AN Amikacin, ATM Aztreonam, C Chloramphenicol, CF Cephalothin, CL Colistin, CZ Cefazolin, D Doxycycline, FEP, Cefepime, FOX Cefoxitin, GM Gentamicin, K Kanamycin, N Neomycin, NA Nalidixic acid, P Penicillin, S Streptomycin, SXT Sulfamethoxazole/trimethoprim, TE Tetracycline